Th2 Cytokine mRNA Expression in Primary Cutaneous CD30-Positive Lymphoproliferative Disorders: Successful Treatment With Recombinant Interferon-γ
- 1 December 1996
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 107 (6) , 827-832
- https://doi.org/10.1111/1523-1747.ep12330845
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- The prognosis of patients with lymphomatoid papulosis associated with malignant lymphomasBritish Journal of Dermatology, 2008
- Human TH1 and TH2 subsets: doubt no morePublished by Elsevier ,2004
- CD7-positive Sézary syndrome with a Th1 cytokine profileJournal of the American Academy of Dermatology, 1996
- Primary cutaneous CD30-positive large-cell lymphoma: A case with fatal outcomeJournal of the American Academy of Dermatology, 1994
- Lymphocyte responses and cytokinesCell, 1994
- Differences in clinical behaviour and immunophenotype between primary cutaneous and primary nodal anaplastic large cell lymphoma of T‐cell or null cell phenotypeHistopathology, 1993
- Spectrum of primary cutaneous CD30 (Ki-1)-positive lymphoproliferative disorders: A proposal for classification and guidelines for management and treatmentJournal of the American Academy of Dermatology, 1993
- Immunophenotypic and genotypic characterization of lymphomatoid papulosisJournal of the American Academy of Dermatology, 1992
- TH1 and TH2 Cells: Different Patterns of Lymphokine Secretion Lead to Different Functional PropertiesAnnual Review of Immunology, 1989
- Interferon alfa-2a in the treatment of cutaneous T cell lymphomaJournal of the American Academy of Dermatology, 1989